PROSTRAKAN
ProStrakan is a rapidly growing specialty pharmaceutical company engaged in the development and commercialisation of prescription medicines for the treatment of unmet therapeutic needs in major markets. With more than 300 people employed by the Company, ProStrakan is headquartered in Scotland with commercial operations throughout the rest of the UK and continental Europe and a US head office. The Company's Development group is located in Galashiels, Scotland and Bedminster, New Jersey, US.
PROSTRAKAN
Industry:
Biopharma Biotechnology
Founded:
1995-01-01
Address:
Galashiels, Scottish Borders, The, United Kingdom
Country:
United Kingdom
Website Url:
http://www.prostrakan.com
Total Employee:
251+
Status:
Active
Contact:
+44 18 9666 4000
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Analytics Google Universal Analytics Apache Google Maps Microsoft Azure DNS GoDaddy SSL OVH
Current Employees Featured
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2014-07-11 | Archimedes Pharma | Archimedes Pharma acquired by ProStrakan | 230 M GBP |
Investors List
3i Group
3i Group investment in Venture Round - ProStrakan
Official Site Inspections
http://www.prostrakan.com Semrush global rank: 10.09 M Semrush visits lastest month: 50
Unable to get host informations!!!
More informations about "ProStrakan"
ProStrakan Group Plc - Home
ProStrakan, the Scotland-based specialty pharmaceutical company, has rebranded as Kyowa Kirin as from the 18th April 2016. ProStrakan was acquired by Tokyo-based Kyowa Hakko …See details»
ProStrakan - Crunchbase Company Profile & Funding
ProStrakan is a rapidly growing specialty pharmaceutical company engaged in the development and commercialisation of prescription medicines for the treatment of unmet therapeutic needs …See details»
ProStrakan - Overview, News & Similar companies | ZoomInfo.com
View ProStrakan (www.prostrakan.com) location in Scottish Borders, United Kingdom , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
ProStrakan - Products, Competitors, Financials, Employees, …
ProStrakan, now known as Kyowa Kirin, is a specialty pharmaceutical company focusing on the development of innovative drugs in the areas of oncology, nephrology, and immunology. The …See details»
ProStrakan Group Plc - Products, Competitors, Financials, …
Oct 8, 2024 ProStrakan Group Plc is a specialty pharmaceutical company focused on developing and commercializing prescription medicines in the fields of oncology, nephrology, …See details»
ProStrakan Group plc: Contact Details and Business Profile
ProStrakan Group plc is a Pharmaceutical Manufacturing, Drug Manufacturing & Research, and Pharmaceuticals company located in London, England with $175000 in revenue and 0 …See details»
ProStrakan - PharmaBoardroom
Feb 13, 2014 ProStrakan is a rapidly growing specialty pharmaceutical company engaged in the development and commercialisation of prescription medicines for the treatment of unmet …See details»
PROSTRAKAN INC DMF, CEP, Written Confirmations, FDF
PROSTRAKAN INC// ProStrakan Group PLC is owned by Kyowa Hakko Kirin Co., Ltd (KHK) of Japan and is one of Europe’s fastest growing specialty pharmaceutical companies. With more …See details»
ProStrakan - Drug pipelines, Patents, Clinical trials - Synapse
Explore ProStrakan with its drug pipeline, therapeutic area, technology platform, 1 news.See details»
ProStrakan - Funding, Financials, Valuation & Investors - Crunchbase
Jan 1, 1999 ProStrakan has raised 1 round. This was a Venture - Series Unknown round raised on Jan 1, 1999. ProStrakan is funded by 3i Group. ProStrakan has acquired Archimedes …See details»
ProStrakan - Tech Stack, Apps, Patents & Trademarks - Crunchbase
ProStrakan is a pharmaceutical company. Start Free Trial . Chrome ExtensionSee details»
ProStrakan - Company Profile - Tracxn
Oct 14, 2024 ProStrakan - Scottish specialty pharma company developing drugs for Oncology, Nephrology and Immunology.. Acquired by Kyowa Hakko Kirin. Raised funding from 1 …See details»
ProStrakan Company Profile | Management and Employees List
Find contact information for ProStrakan. Learn about their Manufacturing market share, competitors, and ProStrakan's email format.See details»
ProStrakan Pharma Company Profile 2024: Valuation, Investors ...
The current valuation of ProStrakan Pharma is 00.000. What is ProStrakan Pharma’s current revenue? The current revenue for ProStrakan Pharma is 000000. When was ProStrakan …See details»
ProStrakan, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore ProStrakan, Inc. with its drug pipeline, therapeutic area, technology platform, 3 literature, Drug:S-401G, RU-58841. ... The statistics for drugs in the Pipeline is the current organization …See details»
Prostrakan | VentureRadar
Morpheus Biolabs USA n/a Morpheus BioLabs is a Contract Research Organization (CRO) that is specialized in providing biomedical research and consulting services to pharmaceuticals, …See details»
Sharewatch: Prostrakan
The Borders-based biotech company last week moved closer to being able to sell its Abstral drug in America. The product, which was accepted for review by the US Food and Drug …See details»
ProStrakan - Contacts, Employees, Board Members, Advisors
Organization. ProStrakan . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. ProStrakan has 1 …See details»
Prostrakan Pharma (Prostrakan Pharma) - 药物管线_专利_临床试 …
了解Prostrakan Pharma (Prostrakan Pharma)公司的药物管线，治疗领域，技术平台，以及它的8项临床试验和2篇文献，药物:格拉司琼。See details»
ProStrakan in £55m rights deal for cancer pain drug - The Scotsman
Jun 4, 2012 DRUGS developer ProStrakan has bought the European rights to Abstral, a medicine used to treat severe pain from cancer, as the Borders-based firm’s Japanese owner …See details»